Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Clinical Status Human RCT | Observational | Animal | In vitro Primarily studied in preclinical and regional aging research contexts, with limited exploratory human data
However, the daily requirement of handling syringes, reconstituting lyophilized powders with bacteriostatic water, and managing injection site reactions poses a significant barrier to entry
In the Phase II trial, 73% to 94% of participants reported side effects with retatrutide, especially at the higher doses of 8 mg and 12 mg once weekly
We also prioritize third-party testing
The average increase in collagen density across all subjects was 28%
US$ 25.34
US$ 29.67
US$ 29.44
US$ 24.40
